Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.82
(
-0.38%
)
Bitcoin
78,189.39
(
-0.11%
)
News Focus
News Focus
Post# of 257441
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Dub Narcotic

Send PM Follow Ignore
Followers 4
Posts 198
Boards Moderated 0
Alias Born 06/06/2007

Dub Narcotic

Re: DewDiligence post# 65786

Wednesday, 09/03/2008 9:41:15 AM

Wednesday, September 03, 2008 9:41:15 AM

Post# of 257441
Dimebon became the clear Alzheimer front-runner at ICAD after they showed effectiveness in trials not run by sketchy Russians. Good for them, although it seems that Dimebon is just a general cognitive enhancer, similar to Aricept and friends, rather than something that attacks a specific disease process.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today